Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
The Factor II activity test measures how well prothrombin, also called Factor II, is working in your blood. Factor II is a protein made by the liver that helps your blood clot when you are injured. It is vitamin K dependent, which means your body needs vitamin K to make it properly.
Clinicians use this test to assess the functional activity of Factor II in plasma. It is often performed when screening tests like the prothrombin time or activated partial thromboplastin time are abnormal, or when there is concern for a specific clotting factor problem.
Too little Factor II activity can lead to easy bruising, nosebleeds, heavy menstrual bleeding, or bleeding after surgery or dental work. Low activity can be inherited, but more commonly it is acquired from conditions such as liver disease, vitamin K deficiency, or use of certain anticoagulant medications. Rarely, the body can make antibodies that interfere with Factor II function.
Your clinician may order this test if you have unexplained bleeding, prolonged screening clotting tests, a suspected rare factor deficiency, or to help sort out the effects of medications that act on the vitamin K pathway. Understanding Factor II activity helps guide treatment choices, such as vitamin K replacement, medication adjustments, or factor replacement in selected cases.
Your result is interpreted alongside other tests like the prothrombin time, activated partial thromboplastin time, and possibly mixing studies. A lower-than-expected Factor II activity suggests reduced production, increased consumption, or interference by an inhibitor. Your clinician will consider your medications, diet, and liver health to pinpoint the cause.
If your result does not fit your symptoms or other tests, your team may repeat the test, check additional clotting factors, evaluate vitamin K status, or look for inhibitors. If you take an anticoagulant, results may reflect the drug’s effect rather than a true deficiency. Discuss any bleeding symptoms and all medications and supplements with your clinician so that follow-up testing and treatment can be tailored to you.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Warfarin and some direct oral anticoagulants can reduce or interfere with measured Factor II activity. Always tell the lab and your clinician about any blood thinners you take.
Poor vitamin K intake, fat malabsorption, or prolonged use of broad-spectrum antibiotics can lower vitamin K levels and reduce Factor II production, leading to lower activity results.
Because Factor II is made in the liver, liver diseases such as hepatitis or cirrhosis can reduce Factor II activity. Related liver tests help with interpretation.
Improper fill volume, delayed processing, or accidental heparin contamination of the sample can artifactually lower activity. Proper collection in citrate tubes and timely processing are important.
Serious infections, disseminated intravascular coagulation, or major surgery can increase clotting factor consumption and lower measured activity during the acute phase.
Hormonal changes can alter overall clotting balance. While Factor II may not change markedly, clinical context in pregnancy or with estrogen use is important for accurate interpretation.
References